Immune System News and Research

RSS

Tuberculosis fourfold the risk for Celiac sufferers

Swedish researchers are suggesting that people with celiac disease, also known as gluten intolerance, have an increased risk of developing tuberculosis (TB).

17 Oct 2006

Why organs fail following massive trauma

Massive trauma, say from a sabertooth tiger attack, meant immediate death for the primitive human.

17 Oct 2006

Vaccine that protects mice against 1918 influenza virus developed

Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.

17 Oct 2006

Topical treatment for psoriasis, eliminates need for injections

Apollo Life Sciences, a Sydney-based biotechnology company, has announced that its topical psoriasis treatment has outperformed current market-leading drugs in preclinical studies.

17 Oct 2006

Discovery of mechanism by which Ebola and Marburg viruses cause disease

Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health, the Centers for Disease Control and Prevention, and the Caribbean Primate Research Center have discovered a key mechanism by which the Filoviruses, Ebola and Marburg, cause disease.

16 Oct 2006

Study points to new strategy for AIDS vaccination

A new HIV study shows how competition among the human immune system's T cells allows the virus to escape destruction and eventually develop into full-blown AIDS.

16 Oct 2006

New technique allows partial-match cell transplants for children with most resistant leukemia

Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.

16 Oct 2006

Researchers identifiy how immune system contributes to nerve fiber damage caused by multiple sclerosis

Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.

16 Oct 2006

Updates on pandemic flu vaccine trials to be presented at 44th Annual IDSA meeting

Preliminary results from clinical trials testing two different pandemic flu vaccine approaches - one a prime-boost strategy using different subtypes of H5N1 vaccines, the other an H5N1 vaccine delivered into the skin (intradermal) rather than the muscle - will be presented at the 44th Annual Meeting of the Infectious Diseases Society of America.

16 Oct 2006

Psoriasis increases the risk of a heart attack

American researchers are suggesting that adults who suffer from psoriasis are at an increased risk of a heart attack.

11 Oct 2006

Latest recall - lettuce with E. coli

In the latest scare over foods contaminated by the bacteria E. coli, another Californian grower has recalled a product, but this time it is not spinach or ground beef, but lettuce.

9 Oct 2006

Suspect ground beef recalled because of E. coli

Suspicions that some minced or ground beef products may be contaminated with a dangerous strain of the E. coli bacteria have forced the recall of 5,200 pounds of the meat in the United States.

8 Oct 2006

Six shot course gives two year protection from hay fever

An experimental vaccine is promising to prevent hay fever symptoms for at least two years, and this is after just six injections.

5 Oct 2006

New bird flu vaccine promises to offer cross-protection

Early clinical trials of a new bird flu vaccine have produced promising results and a phase 3 trial of the cell-based H5N1 flu vaccine is expected to take place early next year.

4 Oct 2006

Flu jab not available in the UK for those most vulnerable

There are fears in the UK that people who are vulnerable to flu infections may well have to wait for their annual injection this season.

2 Oct 2006

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006